Physician profile
Sharon M Lawrence
NPI 1144218454
$1,048.42
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $55.33 · 2022: $106.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $243.46 | 2019-2020 | |
| Pfizer INC. | $141.20 | 2019-2020 | |
| Philips North America LLC | $139.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $109.47 | 2019 | |
| Abbvie INC. | $86.15 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.26 | 2019 | |
| Vanda Pharmaceuticals INC. | $39.67 | 2019 | |
| Biodelivery Sciences International, INC. | $31.16 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $27.92 | 2019 | |
| Novo Nordisk INC | $26.59 | 2019 | |
| Alkermes, INC. | $24.59 | 2019 | |
| Glaxosmithkline, LLC. | $20.09 | 2022 | |
| Boston Scientific Corporation | $19.66 | 2020 | |
| Amarin Pharma, INC. | $19.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.65 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.11 | 2019 | |
| Merck Sharp & Dohme LLC | $14.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.